Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinhu Ganmao San is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine for the treatment of acute upper respiratory tract infections (AURTI) in children, specifically those presenting with the wind-heat pattern. The drug is administered topically via a patch, a delivery method designed to improve compliance in pediatric populations and provide localized or systemic effects through acupoint application. Clinical evaluation focuses on its efficacy in reducing fever (defervescence), shortening recovery time, and alleviating symptoms such as cough and sore throat, either as a monotherapy or in combination with Western medicine. The formulation typically incorporates heat-clearing and detoxifying herbs common to Yin Qiao style prescriptions, such as *Lonicera japonica* and *Forsythia suspensa*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yinhu ganmao san.